Laser treatment for certain prostate tumors guided by MRI images
Part of Cancer, Kidney & urinary clinical trials.
This trial tests whether a precisely targeted laser procedure—guided by MRI images—can treat prostate cancer. It may help some men who have a certain type and location of tumor while aiming to avoid nearby sensitive structures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an active NIH patient enrolled in the specific NIH study 16-C-0010
- Your prostate cancer must be “low to intermediate risk” and not “aggressive,” based on standard pathology, PSA, and biopsy results
- Your tumor must be visible and reachable on MRI (or a related MRI/ultrasound targeting method) and be at least 8 mm away from key structures like the urethra or rectum
- You must have had a prostate MRI at NIH within the last 12 months and a prostate biopsy at NIH within the last 12 months (+2 months)
- You must be able to get MRI with contrast (if needed), and you must be cleared for surgery/anesthesia by NIH
- You must meet basic blood/liver/kidney safety lab levels and be healthy enough for the procedure (and able to attend follow-up)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a laser treatment that targets only the cancerous part of the prostate. It may be an option for men with intermediate-risk prostate cancer who do not want their entire prostate removed.
This trial tests a minimally invasive prostate treatment using MRI guidance and a focal laser to destroy only the cancer spot (not the whole prostate). If you have low-to-intermediate risk, MRI-visible prostate cancer in a limited area, it may help control the cancer while potentially reducing treatment side effects.
This study tests a new, less invasive treatment using targeted microwave ablation (TMA) to destroy prostate cancer tumors. It is designed for men with early-stage, low to intermediate-risk prostate cancer that hasn't spread, offering a possible alternative to surgery or radiation.
This trial tests whether using MRI scans to guide radiation can allow lower doses to the healthy parts of the prostate, potentially reducing side effects. It is for men with intermediate- or high-risk prostate cancer that can be seen on MRI and has not spread.
This trial tests a precise, short course of radiation therapy guided by MRI for men with low or favorable intermediate-risk prostate cancer. It aims to offer effective treatment with fewer sessions and fewer side effects.
This trial tests a stronger, more focused radiation dose to the main tumor inside the prostate using MRI guidance. It aims to improve control of intermediate-risk prostate cancer while possibly reducing side effects.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.